WHOCC - ATC/DDD Index
New search Hide text from Guidelines. C CARDIOVASCULAR SYSTEM. This group comprises substances used for the treatment of cardiovascular conditions. Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting …
WHOCC - ATC/DDD Index
Postal address: WHO Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health Postboks 222 Skøyen 0213 Oslo Norway
WHOCC - ATC/DDD Index
DDD. The DDDs, which will be reviewed in 2024 (3 year revision), are listed here and in the annex I in the printed ATC Index. See also Guidelines: Part III; D Principles for reviewing and changing DDD and Part V; D Requests for changes to DDDs.. To express the DDD several abbreviations are used for units and routes of administration.
WHOCC - ATC/DDD Index
New search Hide text from Guidelines. N NERVOUS SYSTEM N05 PSYCHOLEPTICS. The group is divided into therapeutic subgroups: N05A - Antipsychotics N05B - Anxiolytics N05C - Hypnotics and sedatives. N05C HYPNOTICS AND SEDATIVES. This group comprises preparations with mainly sedative or hypnotic actions.
WHOCC - ATC/DDD Index
New search Hide text from Guidelines. D DERMATOLOGICALS. Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.
WHOCC - ATC/DDD Index
New search Hide text from Guidelines. A ALIMENTARY TRACT AND METABOLISM A02 DRUGS FOR ACID RELATED DISORDERS A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD). Peptic ulcer includes ulcers in the oesophagus, stomach or duodenum. Combinations with H 2-receptor antagonists are classified in A02B. See also A03 - Drugs for functional gastrointestinal disorders.
The DDDs assigned for combination products are based on the main principle of counting the combination as one daily dose, regardless of the number of active ingredients included in the combination.